MedPath

Effects of the Action Observation Therapy and Robotic Rehabilitation on the Upper-Limb Motor Function in Stroke

Not Applicable
Completed
Conditions
Stroke
Registration Number
NCT05590156
Lead Sponsor
Emre Şenocak
Brief Summary

This protocol will investigate the effects of action observation therapy and robotic rehabilitation on upper extremity motor functions in subacute stroke patients. Firstly, for this purpose, conventional rehabilitation approaches will take 60 minutes before both treatment methods in stroke patients. The upper-limb conventional rehabilitation program will be applied to all patients according to their individual needs (60x3x8 minutes/day/week). This program will consist of purposeful clinical exercises with a physiotherapist.

After the conventional rehabilitation, one of the groups will receive action observation therapy, while the other will receive robotic rehabilitation. Both additional treatment methods will also be applied for 60 minutes. Treatment durations of both additional treatments are the same (60x3x8 minutes/day/week). Assessments will be made three times (Beginning, 4th week, 8th week).

Detailed Description

Randomization: The online randomization software (www.randomizer.org) will be used for the study. After randomization, patients will be divided into two groups (AOT group, Robotic group)

Blinding: Due to the nature of the study, patient-practitioner blinding is not possible. But an independent expert will perform the statistical analysis, and single-blind will be provided.

Estimating Sample Size: Gpower 3.1.9.7 software was used for sample size calculation. To calculate the effect size, the study of Lima and Christofoletti was taken as a reference, and the effect size was calculated as 1.29. The alpha error was accepted as 5% and the power of the study was 80%. Accordingly, considering that there may be missing data in the study, it was planned to include a minimum of 30 stroke patients.

Statistical Analysis: Statistical Package for the Social Sciences (SPSS v11.5) program will be used for analysis. Whether the data is normally distributed or not will be questioned by the Shapiro-Wilks test and histogram curves. When the data are normally distributed, Independent Sample T-test will be used for comparisons between groups, and Paired-Sample T-test will be used for comparisons within groups. When the data do not show normal distribution, Mann-Whitney U Test will be used for intergroup comparisons and Wilcoxon Signed Rank Test will be used for in-group comparisons.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Between 18-80 aged
  • Stroke history in last six months
  • Mini-Mental Status Evaluation >24 points,
  • Having an Ability to sit independently,
  • Presence of at least half of the range of motion of all joints for the upper extremity,
  • Spasticity ≤ 2 according to the Modified Ashworth Scale,
  • The Fugl-Meyer Assessment for Upper Extremity score between 20-60,
  • Individuals without visual impairment,
  • Individuals with normal communication and cooperation skills.
Exclusion Criteria
  • Having another neurological disease,
  • Having any orthopedic problems that may affect the upper extremity,
  • Taking neuropsychiatric treatment,
  • Individuals who had a botox history or tendon surgery,
  • Using neuroleptic drugs,
  • Having an ataxia,
  • Individuals who attended less than 80% of the total number of sessions.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Fugl Meyer Assessment for Upper ExtremityEnd of the 8th week

This form is used to detect healing in the upper extremity.

Wolf Motor Function TestEnd of the 8th week

This test is used for the level of motor function.

Secondary Outcome Measures
NameTimeMethod
Functional Independence questionnaireEnd of the 8th week

This form helps determine an individual's level of independence.

Box and Block TestEnd of the 8th week

This test is used to evaluate gross motor function of the upper extremity.

Demographic Data FormBaseline

Informations about the patients

The Stroke-Specific Quality of Life Scale (SS-QoL)End of the 8th week

This is a quality of life assessment scale specific to stroke patients. Individuals with a high quality of life also have a high score.

Trial Locations

Locations (1)

Marmara University

🇹🇷

Istanbul, Turkey

Marmara University
🇹🇷Istanbul, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.